About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Francisco | 5,205 Studies Near You

Clinical TrialsSan Francisco

Clinical Trials in San Francisco

Discover 5,205 clinical trials near San Francisco, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3061-3080 of 5,205 trials

Active not recruitingA Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip SystemA Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System.NCT06564636·San Francisco, California and 9 others CompletedIntegrative Approaches for Cancer Survivorship 2: Project 2The purpose of this study is to develop and test a 6 month manualized Health Education intervention in recent breast cancer survivors.NCT02897544·San Francisco, California RecruitingAchieving Diagnostic Excellence Through Prevention and TeamworkThis study seeks to link a group of hospitals to measure and share the rates of diagnostic errors, to understand underlying causes of diagnostic errors, and develop ways that…NCT05747755·San Francisco, California and 1 other

Find Trials by Condition in San Francisco

Breast Cancerin San Francisco Lung Cancerin San Francisco Prostate Cancerin San Francisco Colorectal Cancerin San Francisco Melanomain San Francisco Leukemiain San Francisco Lymphomain San Francisco Pancreatic Cancerin San Francisco Ovarian Cancerin San Francisco Brain Cancerin San Francisco

Data from ClinicalTrials.govTerms

Active not recruitingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisThe goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving…NCT06001385·Phoenix, Arizona and 31 others

TerminatedTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCCONTESSA is a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with HER2 negative, HR positive LA/MBC previously treated with a taxane in the…NCT03326674·Chandler, Arizona and 206 others

CompletedKarenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00010218·La Jolla, California and 43 others

CompletedSleep and Social Experiences Study 2This study aims to to test effects of sleep loss on perceived discrimination and cardiovascular functioning as well as identify moderators of the racial discrimination and…NCT05166590·San Francisco, California

RecruitingEducational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEPThis will be a randomized interventional study.NCT06975033·San Francisco, California and 2 others

RecruitingVirtual Care Strategies to Improve Participation in Cardiac Rehabilitation Among VeteransHome-based CR (HBCR) is an alternative to traditional CR programs that has comparable efficacy in improving morbidity/mortality and increases access to critical services.NCT05423158·San Francisco, California and 1 other

CompletedSafety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected ChildrenThe purpose of this study is to determine the safety of and immune response to a new human papillomavirus (HPV) vaccine in HIV (Human immunodeficiency virus) infected children…NCT00339040·Alhambra, California and 33 others

RecruitingACTengine® IMA203 Combined With mRNA-4203This purpose of this clinical trial is to evaluate the safety, tolerability and anti-tumor activity of IMA203 in combination with different doses of mRNA-4203.NCT06946225·San Francisco, California and 3 others

TerminatedEndothelial Cell Loss After Cataract SurgeryThe purpose of this study is to compare two cataract surgical technique variations for removing the nucleus of the lens (central part of the lens) in terms of damage to the inner…NCT00932191·San Francisco, California

CompletedWeb-based Mindfulness Meditation in Reducing Distress in Participants With Metastatic Gastrointestinal Cancer and Their CaregiversThis trial studies how well web-based mindfulness meditation works in reducing distress in both participants with gastrointestinal cancer that has spread to other parts of the…NCT03528863·San Francisco, California

CompletedEffect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African AmericansThe current study is part of a large multi-investigator grant to look at the pharmacogenetics of a number of membrane transporters.NCT01681693·San Francisco, California

RecruitingCASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer TrialThis study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward…NCT06949800·San Francisco, California and 1 other

CompletedSafety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple MyelomaThis is a research study to see if a new drug called bortezomib is useful to treat multiple myeloma in people who are newly diagnosed, and have not yet received treatment for…NCT01090921·Little Rock, Arkansas and 10 others

TerminatedA Safety Study of SGN-CD48A in Patients With Multiple MyelomaThis study will test the safety and activity of SGN-CD48A in patients with multiple myeloma. SGN-CD48A will be given on Days 1, 8, and 15 of a 28-day cycle.NCT03379584·San Francisco, California and 5 others

CompletedProgram to Overcome Pelvic Pain StudyTo refine and evaluate the feasibility of procedures for a future full-scale efficacy trial of a group-based therapeutic yoga intervention versus physical conditioning (stretching…NCT04615247·Oakland, California and 2 others

RecruitingKidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.NCT06263426·Birmingham, Alabama and 17 others

CompletedCombined Hormonal Contraceptive Use in High Risk Women: A Longitudinal StudyThis study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera.NCT00361400·Hayward, California and 4 others

PreviousPage 154 of 261Next

Diabetes

in San Francisco

Heart Diseasein San Francisco